KATHARINE HOLT: Open Payments
NPI 1023521556 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 68 payments from 18 companies in 2025. Trend: 2023 $1,332 · 2024 $2,780 · 2025 $1,468
Food & beverage: $1,353Education: $115
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 10 | $183 |
| LEO Pharma Inc. | 10 | $182 |
| Organon LLC | 2 | $159 |
| GENZYME CORPORATION | 7 | $153 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $114 |
| Amgen Inc. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
| Janssen Biotech, Inc. | 1 | $72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $62 |
Products named: DUPIXENT, ADBRY, NEMLUVIO, OTEZLA, VTAMA, TREMFYA, OPZELURA, Bimzelx.
Industry payments across TX — which companies pay providers there.
